Workers will be relocated, if possible, but closing the plant is necessary because of declining global prices for medical devices. No dismissals will go into effect before June 2014.
Biomet designs and manufactures myriad spine and orthopedic devices.
More Articles on Devices:
Study: Total Hip Replacement Revision Rates 3% Higher for Metal-on-Metal Implants
Stryker Net Earnings Dip 34.5% in Q2 From Device Recall Costs
Medical Device Tax Cost Industry $1B Since Jan. 1
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
